People are starting to hear about this and realising the exponential potential it has. A 50M market cap won’t be seen again with the potential to be the “go-to” ED treatment, good cash in the bank and spending under control (no costly EPO in future quarters )- in my opinion LTP will be the market share leader in the game within a few years … of which is a 3-5 billion dollar industry.
There is promise of another nasal delivery spray (not sure for what), potential partnerships and licensing … I am hanging around this stock for a while … there will be some bumps and profit taking (mad if you don’t) but the fundamentals of this company excite me … hahahaha
In search of growth: Pharma deals target precommercial biotech assets, page-13
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.63 |
Change
-0.030(1.81%) |
Mkt cap ! $137.7M | |||
| Open | High | Low | Value | Volume |
| $1.67 | $1.75 | $1.63 | $1.371M | 815.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15898 | $1.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 1618 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| LTP (ASX) Chart |